170 related articles for article (PubMed ID: 33930531)
21. Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer.
Heeren AM; van Luijk IF; Lakeman J; Pocorni N; Kole J; de Menezes RX; Kenter GG; Bosse T; de Kroon CD; Jordanova ES
Cancer Immunol Immunother; 2019 Nov; 68(11):1759-1767. PubMed ID: 31616965
[TBL] [Abstract][Full Text] [Related]
22. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
[TBL] [Abstract][Full Text] [Related]
23. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
24. Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.
Alldredge JK; Tewari KS
Oncologist; 2016 May; 21(5):576-85. PubMed ID: 27026677
[TBL] [Abstract][Full Text] [Related]
25. Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.
Pichler R; Fritz J; Zavadil C; Schäfer G; Culig Z; Brunner A
Oncotarget; 2016 Jun; 7(26):39916-39930. PubMed ID: 27221038
[TBL] [Abstract][Full Text] [Related]
26. CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8
Zhang Y; Wang N; Ding M; Yang Y; Wang Z; Huang L; Zhu W; Mellor AL; Hou X; Zhou C; Yan R; Wang W; Wu S
Front Immunol; 2020; 11():1012. PubMed ID: 32536922
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature.
Philippe A; Rassy M; Craciun L; Naveaux C; Willard-Gallo K; Larsimont D; Veys I
Int J Gynecol Pathol; 2018 Sep; 37(5):482-487. PubMed ID: 28985196
[TBL] [Abstract][Full Text] [Related]
28. The immunohistochemical analysis of antigens such as RCAS1 and B7H4 in the cervical cancer nest and within the fibroblasts and macrophages infiltrating the cancer microenvironment.
Galazka K; Opławski M; Windorbska W; Skret-Magierlo J; Koper K; Basta P; Mach P; Dutch-Wicherek M; Mazur A; Wicherek L
Am J Reprod Immunol; 2012 Jul; 68(1):85-93. PubMed ID: 22530960
[TBL] [Abstract][Full Text] [Related]
29. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
30. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
31. Highly immunosuppressive HLADR
Yang H; Ye S; Goswami S; Li T; Wu J; Cao C; Ma J; Lu B; Pei X; Chen Y; Yu J; Xu H; Qiu L; Afridi S; Xiang L; Zhang X
Int J Cancer; 2020 Apr; 146(7):1993-2006. PubMed ID: 31709528
[TBL] [Abstract][Full Text] [Related]
32. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
33. A case report of recurrent cervical cancer which responded to a combination of biological therapies.
Goto S; Sakai S; Kera J; Suma Y; Soma GI; Takeuchi S
Eur J Gynaecol Oncol; 1994; 15(3):235-40. PubMed ID: 7957329
[TBL] [Abstract][Full Text] [Related]
34. Immune stromal features in cervical squamous cell carcinoma are prognostic factors for distant metastasis: A retrospective study.
Cao L; Sun PL; He Y; Yao M; Gao H
Pathol Res Pract; 2020 Mar; 216(3):152751. PubMed ID: 31776057
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer.
Dorta-Estremera S; Colbert LE; Nookala SS; Yanamandra AV; Yang G; Delgado A; Mikkelson M; Eifel P; Jhingran A; Lilie LL; Welsh J; Schmeler K; Sastry JK; Klopp A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):593-600. PubMed ID: 30017792
[TBL] [Abstract][Full Text] [Related]
37. An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.
Rice AE; Latchman YE; Balint JP; Lee JH; Gabitzsch ES; Jones FR
Cancer Gene Ther; 2015 Sep; 22(9):454-62. PubMed ID: 26337747
[TBL] [Abstract][Full Text] [Related]
38. Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment.
Camisaschi C; Vallacchi V; Castelli C; Rivoltini L; Rodolfo M
Expert Rev Mol Diagn; 2014 Jul; 14(6):643-6. PubMed ID: 24914691
[TBL] [Abstract][Full Text] [Related]
39. CD20
Sato J; Kitano S; Motoi N; Ino Y; Yamamoto N; Watanabe S; Ohe Y; Hiraoka N
Cancer Sci; 2020 Jun; 111(6):1921-1932. PubMed ID: 32277550
[TBL] [Abstract][Full Text] [Related]
40. New strategies in advanced cervical cancer: from angiogenesis blockade to immunotherapy.
Tewari KS; Monk BJ
Clin Cancer Res; 2014 Nov; 20(21):5349-58. PubMed ID: 25104084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
